Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT07534241 Sponsor: University of Lahore Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT07534241
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between the ages of 35 and 65 years old.
  • People with a body weight in a range considered neither underweight nor overweight, based on a standard height-to-weight calculation (BMI between 18.5 and 30).
  • People whose routine blood count results fall within certain ranges for white blood cells, red blood cells, haemoglobin, and platelets (confirm specific values with trial site).
  • People with certain abnormal cholesterol or fat levels in the blood, including elevated LDL, total cholesterol, or triglycerides at specific levels (confirm exact ranges with trial site).
  • People with elevated liver enzyme levels above certain thresholds on a standard liver function test (confirm specific values with trial site).
  • People with raised levels of certain inflammation markers in the blood, including CRP, IL-6, and TNF-α, above specified levels (confirm exact values with trial site).
  • People with higher than normal blood sugar levels, either when fasting or after a meal, above certain measured thresholds (confirm specific values with trial site).

Who may not be able to join:

  • People who have been diagnosed with serious heart disease, liver failure, or significant kidney problems.
  • Women who are pregnant or currently breastfeeding.
  • People who are currently taking certain cholesterol-lowering medications, such as statins or related drugs.
  • People who have a known allergy to mushrooms.
  • People who have been diagnosed with coeliac disease or other long-term digestive conditions, such as Crohn's disease or ulcerative colitis.
  • People who have a history of cancer.
  • People who have taken part in another clinical trial within the past three months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 03018661160

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Lahore
Registry
ClinicalTrials.gov
Start date
2 October 2025
Est. completion
1 February 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

LIPID PROFILE

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov